NEW YORK (TheStreet) -- CHANGE IN RATINGSBlackrock BLK was initiated with an Overweight rating at JP Morgan. Equity and fixed-income ETF's can drive growth. Davita DVA was started with an Overweight rating at JP Morgan, which set a $125 price target. HCP purchase positions the company well for potential future growth. Freeport-McMoran FCX was upgraded from Hold to Buy at Deutsche Bank with a $40 price target. Stock appears oversold at current levels. Flir Systems FLIR was upgraded from Neutral to Buy at Sterne Agee with a $30 price target. Company appears to be back on the path toward solid growth. Sandridge SD was downgraded to Hold at Keybanc. Permian asset sale leaves questions about the company's remaining properties. Silgan SLGN was downgraded from Neutral to Sell at Goldman Sachs. Valuation call, based on a $42 price target.
STOCK COMMENTS / EPS CHANGESBed Bath & Beyond BBBY numbers cut at Credit Suisse. Shares of BBBY now seen reaching $75, according to Credit Suisse. Estimates also reduced, given the company's new guidance. Outperform rating. CVS Caremark CVS numbers increased at Jefferies. CVS estimates were raised through 2014, Jefferies said. Company can expand margins and repurchase more shares. Buy rating and new $58 price target.
Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE. Sign up today to get e-mail alerts before every trade.
- Investment & Company Information